We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+10.55%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$3.14B
AUM Growth
+$728M
Cap. Flow
+$534M
Cap. Flow %
17.01%
Top 10 Hldgs %
37.86%
Holding
6,828
New
511
Increased
3,030
Reduced
2,253
Closed
625

Sector Composition

Rank Sector Weight
1 Technology 21.21%
2 Consumer Discretionary 7.37%
3 Financials 6.36%
4 Healthcare 5.92%
5 Industrials 5.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UNL icon
5251
United States 12 Month Natural Gas Fund
UNL
$13.3M
$3K ﹤0.01%
295
-78
-21% -$1.03K
VIPS icon
5252
Vipshop
VIPS
$6.8B
$3K ﹤0.01%
200
-15,026
-99% -$223K
WEST icon
5253
Westrock Coffee
WEST
$820M
$3K ﹤0.01%
240
-435
-64% -$5.36K
WHLR
5254
Wheeler Real Estate Investment Trust
WHLR
$383K
0
WRAP icon
5255
Wrap Technologies
WRAP
$97.4M
$3K ﹤0.01%
+2,167
New +$4.49K
XTNT icon
5256
Xtant Medical Holdings
XTNT
$43.8M
$3K ﹤0.01%
+5,279
New +$3.85K
YCBD icon
5257
cbdMD
YCBD
$5.93M
$3K ﹤0.01%
42
TRUG icon
5258
TruGolf
TRUG
$971K
$3K ﹤0.01%
1
ATYR
5259
aTyr Pharma
ATYR
$54.2M
$3K ﹤0.01%
1,281
-16,162
-93% -$35.4K
SAIH
5260
SAIHEAT Ltd
SAIH
$35.3M
$3K ﹤0.01%
+170
New +$3.42K
BLNE
5261
Beeline Holdings
BLNE
$36.4M
$3K ﹤0.01%
44
YOTA
5262
DELISTED
Yotta Acquisition Corporation Common Stock
YOTA
$3K ﹤0.01%
262
+77
+42% +$783
GATE
5263
DELISTED
Marblegate Acquisition Corp. Class A Common Stock
GATE
$3K ﹤0.01%
253
-234
-48% -$2.36K
VINC
5264
DELISTED
Vincerx Pharma, Inc. Common Stock
VINC
$3K ﹤0.01%
148
+15
+11% +$336
PMD
5265
DELISTED
Psychemedics Corporation
PMD
$3K ﹤0.01%
448
+96
+27% +$532
NVEI
5266
DELISTED
Nuvei Corporation Subordinate Voting Shares
NVEI
$3K ﹤0.01%
60
-4,748
-99% -$166K
SEDA.U
5267
DELISTED
SDCL EDGE Acquisition Corporation Units, each consisting of one Class A ordinary share and one-half of one redeemable warrant
SEDA.U
$3K ﹤0.01%
300
+200
+200% +$2.04K
FIACU
5268
DELISTED
Focus Impact Acquisition Corp. Unit
FIACU
$3K ﹤0.01%
248
XFIN
5269
DELISTED
ExcelFin Acquisition Corp Class A Common Stock
XFIN
$3K ﹤0.01%
+279
New +$2.88K
PRST
5270
DELISTED
Presto Technologies, Inc. Common Stock
PRST
$3K ﹤0.01%
1,733
-2,685
-61% -$7.27K
AINC
5271
DELISTED
Ashford Inc.
AINC
$3K ﹤0.01%
202
-355
-64% -$4.72K
CULL
5272
DELISTED
Cullman Bancorp Inc.
CULL
$3K ﹤0.01%
288
+221
+330% +$2.56K
CAMP
5273
DELISTED
CalAmp Corp.
CAMP
$3K ﹤0.01%
39
-576
-94% -$56.3K
TTOO
5274
DELISTED
T2 Biosystems, Inc
TTOO
$3K ﹤0.01%
67
+17
+34% +$1.86K
NBSE
5275
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
$3K ﹤0.01%
889
+1
+0.1% +$5

Similar funds

Tower Research Capital (TRC)'s Q1 2023 Portfolio in Review

As of Q1 2023, Tower Research Capital (TRC) held 6,828 positions worth $3.14B, up 30% from $2.41B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Tower Research Capital (TRC) deployed $534M of net new capital in Q1 2023, opening 511 new positions and adding to 3,030 existing holdings. Its largest new stake was iShares Russell 2000 Growth ETF: 100,561 shares worth $22.8M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $52.8M trimmed.

  • Tower Research Capital (TRC)'s largest Q1 2023 buy was iShares Russell 2000 Growth ETF: 100,561 shares worth $22.8M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q1 2023, an estimated $204M increase.
  • Tower Research Capital (TRC)'s biggest Q1 2023 reduction was iShares Russell 2000 ETF, cutting an estimated $52.8M.
  • Tower Research Capital (TRC) fully exited Myovant Sciences Ltd. in Q1 2023, selling an estimated $7.26M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 38% of its $3.14B portfolio in Q1 2023.
  • Tower Research Capital (TRC) opened 511 new positions and closed 625 in Q1 2023.
  • Tower Research Capital (TRC)'s portfolio value rose 30% quarter-over-quarter to $3.14B.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2023, filed 9 May 2023.